In a groundbreaking move that reshapes the landscape of American healthcare, President Donald Trump has unveiled new partnerships with pharmaceutical giants Eli Lilly and Novo Nordisk that promise to ...

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices ...

US President Donald Trump announced deals Thursday with pharmaceutical giants Eli Lilly and Novo Nordisk to lower the prices ...

Eli Lilly & Company (NYSE:LLY) continues to stand out as a significant player in the pharmaceutical sector, particularly recognized for its robust earnings growth projections over the next five years.

Eli Lilly and Novo Nordisk agree to expand access and cut prices for Zepbound and Wegovy • Medicare to begin covering obesity ...

Trump announces deal with Eli Lilly, Novo Nordisk to lower cost of GLP-1 weight loss drugs Wegovy, Zepbound. Here's what to know and Medicare coverage ...

President Donald Trump on Thursday announced a deal with drugmakers Eli Lilly and Novo Nordisk to lower prices for their ...

Medicare beneficiaries will soon be able to get obesity and Type 2 diabetes drugs for a $50 copay. But there are some ...

President Donald Trump unveiled steep discounts on GLP-1 weight loss drugs in deals with pharmaceutical giants Eli Lilly and ...

An investigational once-weekly amylin receptor agonist conferred substantial weight loss across six different dosing regimens for adults with overweight or obesity, researchers reported in a phase 2 ...

Cedar Rapids' 1st Avenue bridge will be closed through Friday, Nov. 7 for updates to the flood control system.The city will ...

Eli Lilly and Novo Nordisk officials have agreed to lower the cost of GLP-1 obesity drugs for Medicaid and Medicare ...